SR

Srinivasa Rao Karanam

Active Director Director DIN 08163442
DIN 08163442 First appointment Jun 2018 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Srinivasa Rao Karanam

Data last updated:

Srinivasa Rao Karanam is a Director at Vaishnavi Institute Of Medical Sciences And Hospitals Limited (since 2018). The company operates in Healthcare.

DIN 08163442
Primary Designation Director
Industry Healthcare
First Appointment 21 Jun 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Jun 20182018Active

Directorship timeline

Open interactive timeline →
Vaishnavi Institute Of Medical Sciences And Hospitals Limited
Premium access

Shareholding and investment profile for Srinivasa Rao Karanam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srinivasa Rao Karanam

Srinivasa Rao Karanam currently holds 1 directorship: Vaishnavi Institute Of Medical Sciences And Hospitals Limited (Director, since 21 Jun 2018).

Srinivasa Rao Karanam was first appointed on 21 Jun 2018 as Director at Vaishnavi Institute Of Medical Sciences And Hospitals Limited.

The current boards of Srinivasa Rao Karanam's companies include Bala Krishna Penugonda (Vaishnavi Institute Of Medical Sciences And Hospitals Limited), Prasad Veera Vara Batchu (Vaishnavi Institute Of Medical Sciences And Hospitals Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available